Core Viewpoint - On November 21, Weigao Orthopedics experienced a decline of 3.62% in stock price, with a trading volume of 48.15 million yuan, indicating potential market volatility and investor sentiment concerns [1]. Financing Summary - On the same day, Weigao Orthopedics had a financing buy-in amount of 9.15 million yuan and a financing repayment of 15.83 million yuan, resulting in a net financing outflow of 6.68 million yuan [1]. - The total financing and securities balance as of November 21 is 142 million yuan, which accounts for 1.25% of the circulating market value, indicating a high level of financing activity compared to the past year [1]. - The company had no shares repaid in securities lending on November 21, with 300 shares sold short, amounting to 8,541 yuan at the closing price, and a securities lending balance of 15.23 million yuan, also at a high level compared to the past year [1]. Financial Performance - For the period from January to September 2025, Weigao Orthopedics reported a revenue of 1.11 billion yuan, reflecting a year-on-year growth of 2.12%, while the net profit attributable to shareholders was 207 million yuan, showing a significant increase of 26.24% [2]. - The company has distributed a total of 575 million yuan in dividends since its A-share listing, with 367 million yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Weigao Orthopedics reached 10,700, an increase of 18.33% from the previous period, while the average circulating shares per person decreased by 15.49% to 37,418 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the seventh largest, holding 3.44 million shares, an increase of 392,000 shares from the previous period, while Penghua Medical Technology Stock A is a new entrant as the tenth largest shareholder with 1.10 million shares [3].

Core Viewpoint - Weigao Orthopedics has shown a mixed financial performance with a slight decrease in revenue but a significant increase in net profit, indicating potential resilience in profitability despite revenue challenges [2]. Financing Summary - On October 9, Weigao Orthopedics experienced a financing buy-in of 19.40 million yuan, with a net buy of 11.10 million yuan, reflecting strong investor interest [1]. - The total financing and securities balance reached 147 million yuan, accounting for 1.11% of the circulating market value, which is above the 90th percentile of the past year, indicating a high level of financing activity [1]. - The short-selling activity was low, with no shares repaid and only 700 shares sold, resulting in a short-selling balance of 6.62 thousand yuan, below the 40th percentile of the past year [1]. Financial Performance - For the first half of 2025, Weigao Orthopedics reported a revenue of 741 million yuan, a year-on-year decrease of 1.28%, while the net profit attributable to shareholders increased by 52.43% to 142 million yuan [2]. - Cumulatively, the company has distributed 535 million yuan in dividends since its A-share listing, with 327 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders increased by 1.46% to 9,034, while the average circulating shares per person decreased by 1.44% to 44,277 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 3.05 million shares, a decrease of 746,300 shares compared to the previous period [3].